Huvepharma Inc.August 10, 2021

FDA 483 - Huvepharma Inc. - August 10, 2021

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Huvepharma Inc.

Record Details

Huvepharma Inc, a veterinary drug manufacturer in Saint Louis, MO, received a Form 483 with three observations during an FDA inspection. The firm was cited for deficiencies in controlling drug product labeling, failing to follow pest control procedures, and not adequately verifying testing methods. These issues highlight concerns with quality control and adherence to established operational protocols.

Company: Huvepharma Inc.
Inspection Date: August 10, 2021
Product Type: Veterinary
Office: Division of Human and Animal Food Operations - West II
People: Torrey M. Ward
Carl A. Huffman (Supervisory Consumer Safety Officer)

Open in Dashboard

ID · 6866983a-b06a-4bbb-b48d-07e0dfb6f7b7